Stamford, CT -- (SBWIRE) -- 12/10/2013 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: DETOUR GOLD CORP (OTCMKTS:DRGDF), Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT), BG Group plc (ADR) (OTCMKTS:BRGYY), Titan Pharmaceuticals, Inc. (OTCBB:TTNP)
DETOUR GOLD CORP (OTCMKTS:DRGDF) opened the session at $3.42, trading in a range of $3.41 - $3.67, and closed at $3.65. The stock showed a positive performance of +8.45% in the last trading session. The stock traded on a volume of 61,175 shares and the average volume of the stock remained 101,357 shares. Detour Gold Corporation engages in the acquisition, exploration, and development of mineral property interests in Canada. The company primarily explores for gold. It primarily holds a 100% interest in the Detour Lake project covering an area of approximately 566 square kilometers in Northeastern Ontario. The company?s Detour Lake property includes approximately 349 unpatented mining claims, 39 mining leases, and 6 patented claims in the District of Cochrane; and a group of claims located in Massicotte Township, Québec. Detour Gold Corporation was founded in 2006 and is headquartered in Toronto, Canada.
For How Long DRGDF will Fight for Profitability? Read This Trend Analysis report
Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT) traded 920,965 shares in the last business day while the average volume of the stock remained 498,034 shares. The stock showed a positive movement of +0.60% to end at $1.00. The 52 week range of the stock remained $0.50 - $1.14. Provectus Pharmaceuticals, Inc., a development-stage pharmaceutical company, engages in developing pharmaceuticals for oncology and dermatology indications. The company?s product line includes PV-10, a Phase II study completed drug candidate for metastatic melanoma, a Phase I study completed candidate for breast cancer, and a Phase I protocol expansion candidate for liver metastasis; and PH-1.
For How Long PVCT’s Gloss will Attract Investors? Find out via this report
BG Group plc (ADR) (OTCMKTS:BRGYY) reported 58,753 shares were exchanged during the last trade, while the average volume is about 107,544 shares. The stock escalated +1.65% and finished the day at $20.33. The beta of the stock is recorded at 0.91. BG Group plc operates as an integrated natural gas company worldwide. The company?s Upstream segment engages in the exploration, development, production, liquefaction, and marketing of hydrocarbons with a focus on natural gas. This segment has proved and probable reserves of 7 189 million barrels of oil equivalent. Its Liquefied Natural Gas (LNG) Shipping & Marketing segment is involved in the purchase, shipping, marketing, and sale of LNG, as well as regasified natural gas.
For How Long BRGYY’s Gloss will Attract Investors? Find out via this report
Titan Pharmaceuticals, Inc. (OTCBB:TTNP) the stock decreased -1.41% and finished the session at $0.700. Traded with volume of 262,025 shares in the prior session and the average volume of the stock remained 248,618 shares. Titan Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing proprietary therapeutics for the treatment of serious medical disorders in the United States. The company offers Fanapt (iloperidone), an atypical antipsychotic for the treatment of schizophrenia. It is involved in developing Probuphine, an investigational subdermal implant for the treatment of opioid dependence.
Will TTNP Get Buyers Even After The Recent Rally? Find Out Here
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Read full disclaimer at: http://otcstockpicks.net/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)